Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Stawiski

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Human Genetics|December 7, 2019
Identification of African-Specific Admixture between Modern and Archaic HumansJeffrey D Wall, Aakrosh Ratan, Eric Stawiski, et al.
Journal of Virology|August 27, 2009
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistanceMadhavi Kolli, Eric Stawiski, Colombe Chappey, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistanceSoumi Gupta, Signe Fransen, Ellen E Paxinos, et al.
Virology|November 13, 2010
Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1Wei Huang, Arne Frantzell, Jonathan Toma, et al.
Nature Genetics|March 29, 2011
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptaseTrevor Hinkley, João Martins, Colombe Chappey, et al.
Epidemics|March 1, 2011
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environmentsJoão Z R Martins, Colombe Chappey, Mojgan Haddad, et al.
Journal of Virology|February 4, 2011
Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumabJonathan Toma, Steven P Weinheimer, Eric Stawiski, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus compositionSigne Fransen, Gary Bridger, Jeannette M Whitcomb, et al.
Journal of Virology|March 21, 2008
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope proteinWei Huang, Jonathan Toma, Signe Fransen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Human Genetics|December 7, 2019
Identification of African-Specific Admixture between Modern and Archaic HumansJeffrey D Wall, Aakrosh Ratan, Eric Stawiski, et al.
Journal of Virology|August 27, 2009
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistanceMadhavi Kolli, Eric Stawiski, Colombe Chappey, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistanceSoumi Gupta, Signe Fransen, Ellen E Paxinos, et al.
Virology|November 13, 2010
Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1Wei Huang, Arne Frantzell, Jonathan Toma, et al.
Nature Genetics|March 29, 2011
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptaseTrevor Hinkley, João Martins, Colombe Chappey, et al.
Epidemics|March 1, 2011
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environmentsJoão Z R Martins, Colombe Chappey, Mojgan Haddad, et al.
Journal of Virology|February 4, 2011
Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumabJonathan Toma, Steven P Weinheimer, Eric Stawiski, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus compositionSigne Fransen, Gary Bridger, Jeannette M Whitcomb, et al.
Journal of Virology|March 21, 2008
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope proteinWei Huang, Jonathan Toma, Signe Fransen, et al.
Pageof 3